Tag: Preoperative testing

Study: Stool tests show promise in reducing colonoscopies for post-polypectomy colorectal cancer surveillance

Editor's Note Stool-based testing strategies could significantly reduce the number of colonoscopies required for post-polypectomy colorectal cancer (CRC) surveillance while maintaining equivalent long-term outcomes in cancer incidence and mortality, according to research published August 30 in Gastroenterology. Conducted in the Netherlands, the cross-sectional observational study compared three stool tests—multitarget stool…

Read More

By: Matt Danford
November 1, 2024
Share

Study: standard preoperative fasting guidelines safe for GLP-1 patients

Editor's Note Preoperative use of GLP-1 receptor agonists (RA) medications such as Ozempic and Wegovy is safe, according to a study published in the June issue of the American Journal of Gastroenterology. Controversy has swirled around these drugs due to the risk of slowed stomach emptying increasing a patient’s odds…

Read More

By: Matt Danford
June 7, 2024
Share

Study: Preoperative weight loss offers little benefit for bariatric surgery patients

Editor's Note Research shows perioperative weight loss does not consistently improve outcomes or OR times in patients undergoing primary bariatric procedures, including laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (RYGB). The findings were published in the June issue of the Journal of the American College of Surgeons. Using…

Read More

By: Matt Danford
June 3, 2024
Share

FDA approves imaging drug for detecting cancer after lumpectomy

Editor's Note The US Food and Drug Administration (FDA) approved Lumisight (pegulicianine), a fluorescent imaging drug used to detect cancerous tissue during lumpectomy, on April 17. Administered intravenously prior to surgery, Lumisight is designed for use with the Lumicell Direct Visualization System (DVS) or another imaging device that is FDA-approved…

Read More

By: Matt Danford
April 22, 2024
Share

Blood test could help identify risk of sepsis, organ failure in children

Editor's Note Measuring gene activity in blood samples could help determine whether a child is at risk of sepsis and organ failure, according to findings published March 18 in The Lancet Child & Adolescent Health.  It is often difficult for clinicians to diagnose sepsis because the symptoms are similar to…

Read More

By: Brita Belli
March 29, 2024
Share

Study makes case against preoperative urine culture for most surgical procedures

JAMA (healthcare publication) Network logo

Editor's Note Findings published March 4 in Jama Network show that preoperative urine culture is a low-value intervention for most surgical patients and should be de-implemented. Despite guidelines to the contrary from Infectious Diseases Society of America and the American College of Physicians, preoperative urine testing and antibiotic treatment persists…

Read More

By: Matt Danford
March 25, 2024
Share

AI screening identifies patients’ risky preoperative alcohol use

Editor's Note: A recent study suggests artificial intelligence (AI) can be valuable for identifying patients who consumed risky amounts of of alcohol prior to surgery. Findings appeared in the journal Alcohol, Clinical and Experimental Research on January 8. For the study, researchers extracted 3 years of text-based clinical records from…

Read More

By: Brita Belli
January 25, 2024
Share

Coordinating surgical care means precise staff handoffs

In every OR, the complicated dance of surgical care coordination—the series of handoffs between stakeholders throughout the surgery lifecycle—is performed mainly in the background. Those stakeholders include physician offices, schedulers, preadmission testing, insurance verification, vendors, sterile processing, supply chain, anesthesia, and surgical staff. But what does it look like when…

Read More

By: Carisa Brewster and Jonathan Reimer
January 23, 2024
Share

FDA: Class I recall of Quidel Triage Cardiac Panels

Editor's Note The Food and Drug Administration (FDA), on July 17, identified the recall by Quidel Cardiovascular Inc of its Quidel Triage Cardiac Panels as Class I, the most serious. The recall was initiated because of reports of inaccurate tests showing lower than expected troponin levels in samples. A falsely…

Read More

By: Judy Mathias
July 19, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat